BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 19644886)

  • 41. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
    Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
    Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
    Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
    Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pan-DR-binding Hsp60 self epitopes induce an interleukin-10-mediated immune response in rheumatoid arthritis.
    de Jong H; Lafeber FF; de Jager W; Haverkamp MH; Kuis W; Bijlsma JW; Prakken BJ; Albani S
    Arthritis Rheum; 2009 Jul; 60(7):1966-76. PubMed ID: 19565483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
    Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
    Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
    Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
    Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
    J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
    Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
    Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction.
    Kim KW; Cho ML; Kim HR; Ju JH; Park MK; Oh HJ; Kim JS; Park SH; Lee SH; Kim HY
    Arthritis Rheum; 2007 Apr; 56(4):1076-86. PubMed ID: 17393416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
    Catalano A
    J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
    Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
    Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis.
    Hasselberg A; Schön K; Tarkowski A; Lycke N
    Arthritis Rheum; 2009 Jun; 60(6):1672-82. PubMed ID: 19479868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IL-17 increases cadherin-11 expression in a model of autoimmune experimental arthritis and in rheumatoid arthritis.
    Park YE; Woo YJ; Park SH; Moon YM; Oh HJ; Kim JI; Jin HS; Baek SH; Kim GT; Lee JH; Cho ML; Kim SI
    Immunol Lett; 2011 Oct; 140(1-2):97-103. PubMed ID: 21798287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of collagen-induced arthritis by Natura-alpha via regulation of Th-1/Th-17 responses.
    Glatigny S; Blaton MA; Mencher SK; Mistou S; Lucas B; Fournier C; Wang LG; Chiocchia G
    Eur J Immunol; 2010 Feb; 40(2):460-9. PubMed ID: 20077403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
    Miellot A; Zhu R; Diem S; Boissier MC; Herbelin A; Bessis N
    Eur J Immunol; 2005 Dec; 35(12):3704-13. PubMed ID: 16304639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis.
    Matsui T; Nakata N; Nagai S; Nakatani A; Takahashi M; Momose T; Ohtomo K; Koyasu S
    J Nucl Med; 2009 Jun; 50(6):920-6. PubMed ID: 19443596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Collagen-induced arthritis as a model for rheumatoid arthritis.
    Williams RO
    Methods Mol Med; 2004; 98():207-16. PubMed ID: 15064442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
    Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
    Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.